203 related articles for article (PubMed ID: 27310036)
1. Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
Borghini S; Ferrera D; Prigione I; Fiore M; Ferraris C; Mirisola V; Amaro AA; Gueli I; Zammataro L; Gattorno M; Pfeffer U; Ceccherini I
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S121-S128. PubMed ID: 27310036
[TBL] [Abstract][Full Text] [Related]
2. Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.
Karagianni P; Nezos A; Ioakeim F; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):86-89. PubMed ID: 30418111
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
[TBL] [Abstract][Full Text] [Related]
4. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
[TBL] [Abstract][Full Text] [Related]
5. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
Radhakrishna SM; Grimm A; Broderick L
BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
[TBL] [Abstract][Full Text] [Related]
7. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
[TBL] [Abstract][Full Text] [Related]
8. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
Cudrici C; Deuitch N; Aksentijevich I
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
[TBL] [Abstract][Full Text] [Related]
9. Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Pucino V; Vitale A; Lucherini OM; Obici L; Matarese G
Clin Exp Rheumatol; 2017; 35 Suppl 104(2):13-14. PubMed ID: 28375838
[No Abstract] [Full Text] [Related]
10. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
[TBL] [Abstract][Full Text] [Related]
11. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
Khabazi A; Maralani M; Andalib S; Sakhinia E
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
Front Immunol; 2020; 11():576152. PubMed ID: 33162992
[No Abstract] [Full Text] [Related]
13. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG
Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507
[TBL] [Abstract][Full Text] [Related]
14. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic features of Chinese adult patients with tumour necrosis factor receptor-associated periodic fever syndrome.
Zhao M; Luo Y; Wu D; Yang Y; Sun Y; Wang R; Shen M
Rheumatology (Oxford); 2020 Aug; 59(8):1969-1974. PubMed ID: 31774538
[TBL] [Abstract][Full Text] [Related]
16. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
[TBL] [Abstract][Full Text] [Related]
17. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
[TBL] [Abstract][Full Text] [Related]
18. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
[TBL] [Abstract][Full Text] [Related]
19. Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.
Negm OH; Singh S; Abduljabbar W; Hamed MR; Radford P; McDermott EM; Drewe E; Fairclough L; Todd I; Tighe PJ
Clin Exp Immunol; 2019 Sep; 197(3):352-360. PubMed ID: 31009059
[TBL] [Abstract][Full Text] [Related]
20. Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three
Harrison SR; Scambler T; Oubussad L; Wong C; Wittmann M; McDermott MF; Savic S
Front Immunol; 2018; 9():173. PubMed ID: 29467762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
